The presence of ANNA-1 and accompanying SCLC is prototypic, but subacute sensory neuronopathy can also arise in the setting of CRMP-5, amphiphysin, and MAP1B antibodies [67, 68, 69•, 71]. This evidence concerns the gene DPYSL5 and small cell lung carcinoma.